Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP802-247 for wound healing after Mohs surgery
NCT01359735Phase 2Completed
- Sponsor
- Healthpoint Biotherapeutics
- Start
- May 2011
- Primary completion
- Nov 2011
- Modality
- Implantable Devices, Implantable Hydrogels, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of HP-802-247 in surgical wound, sponsored by Healthpoint Biotherapeutics. Started May 2011; status: completed.
02
Drugs
HP-802-247
03
Conditions
surgical wound
Beyond the preview
Go deeper on NCT01359735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01359735.